May 27, 2021 4:05pm EDT Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 25, 2021 8:30am EDT Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
May 13, 2021 4:05pm EDT Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
May 04, 2021 5:30am EDT Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021
Apr 22, 2021 5:30am EDT Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
Apr 14, 2021 5:30am EDT Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
Mar 25, 2021 5:30am EDT Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) (varenicline) in Addiction
Mar 16, 2021 5:30am EDT Achieve Life Sciences to Participate in M-Vest and Maxim Group Inaugural Emerging Growth Virtual Conference
Mar 15, 2021 6:30am EDT Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of Directors